Mitra Industries

Peritoneal Dialysis

Multi Chamber Low GDP Bag for Peritoneal Dialysis

Mitra Tri-Choice is a 3-in-1 multi-chamber bag system designed to support solution choice and patient care in Peritoneal Dialysis.

Mitra Tri-Choice multi-chamber CAPD fluid bag

Tri-Choice offers 1.5 percent, 2.5 percent, and 3.85 percent dextrose monohydrate within a single bag. This helps clinicians adjust the final solution based on patient needs.

Peritoneal Dialysis works by creating an osmotic gradient across the peritoneal membrane through dextrose. The dextrose in the CAPD solution makes it hyperosmolar to plasma, which supports the transfer of toxic substances and metabolites from blood into the dialysate.

Key Features

  • 01

    Enhanced Safety Through Separation

    Dextrose solutions at lower pH levels are autoclaved separately from other electrolytes. This helps prevent the formation of Glucose Degradation Products.

  • 02

    Tailored Osmolarity

    Tri-Choice allows adjustment of final solution osmolarity based on each patient's needs.

  • 03

    Solution Customisation

    The multi-chamber system gives a choice of 1.5 percent, 2.5 percent, and 3.85 percent dextrose monohydrate in the same bag.

  • 04

    Optimal Mixture Before Use

    The solution is mixed just before use. This helps create low GDP Peritoneal Dialysis fluid with pH close to neutral.

Key Benefits

  • 01

    Neutral pH

    Supports peritoneal membrane integrity.

  • 02

    Low GDP

    Helps reduce cellular damage.

  • 03

    Reduced Membrane Alterations

    May help slow fibrosis and vessel dysfunction.

  • 04

    Lower Mortality Risks

    May help reduce inflammation and oxidative stress.

  • 05

    Better Residual Renal Function

    Supports gentler therapy and kidney function preservation.

  • 06

    Reduced Infusion Pain

    Supports a more comfortable exchange experience.

  • 07

    Higher Patient Satisfaction

    Helps improve comfort, confidence, and quality of life.

Specifications

Formulation
System
Multi-chamber (3-in-1) low GDP bag
Dextrose Concentrations
1.5%, 2.5%, and 3.85% dextrose monohydrate in a single bag
Therapy
Continuous Ambulatory Peritoneal Dialysis (CAPD)

Specifications to be validated against approved product brochures.

Request Details for Tri-Choice

Connect with Mitra for specifications, formulation, catalogue, and product support.